Treating Depression: Are Placebo Equally Effective Equally Antidepressants? (60 Minutes)

After watching, Treating Depression: Is at that spot a placebo effect? on threescore Minutes, I had to inquire myself, if dementia patients were enrolled inwards a perpetual clinical lawsuit where they received placebo, would it brand a difference?

Irving Kirsch

Do antidepressants work?

Since the introduction of Prozac inwards the 1980s, prescriptions for antidepressants have got soared 400 percent, alongside 17 i thou one thousand Americans currently taking some shape of the drug. But how much goodness is the medication itself doing?

"The divergence betwixt the outcome of a placebo in addition to the outcome of an antidepressant is minimal for most people," says Harvard scientist Irving Kirsch. Will Kirsch's research, in addition to the move of others, alter the $11.3 billion antidepressant industry? Lesley Stahl investigates.

Subscribe to the

Email:

How the powerful placebo outcome works. This 5 infinitesimal video is fascinating.

The next script is from "Treating Depression" which aired on Feb. 19, 2012. Lesley Stahl is the correspondent. Richard Bonin, producer.

The medical community is at nation of war - battling over the scientific inquiry in addition to writings of a psychologist named Irving Kirsch. The struggle is virtually antidepressants, in addition to Kirsch's questioning of whether they work.

Kirsch's views are of vital involvement to the 17 i thou one thousand Americans who accept the drugs, including children as immature as 6 in addition to to the pharmaceutical manufacture that brings inwards $11.3 billion a yr selling them.

Irving Kirsch is the associate managing director of the Placebo Studies Program at Harvard Medical School, in addition to he says that his inquiry challenges the rattling effectiveness of antidepressants.

Irving Kirsch: The divergence betwixt the outcome of a placebo in addition to the outcome of an antidepressant is minimal for most people.

Lesley Stahl: So you're proverb if they took a saccharide pill, they'd have got the same effect?

Irving Kirsch: They'd have got almost as large an outcome in addition to whatever divergence at that spot would live would live clinically insignificant.

Stahl: But people are getting amend taking antidepressants. I know them.

Kirsch: Oh, yes.

Stahl: We all know them.

Kirsch: People teach amend when they accept the drug. But it's non the chemic ingredients of the drug that are making them better. It's largely the placebo effect.

Irving Kirsch's specialty has been the report of the placebo effect: the taking of a dummy pill without whatsoever medication inwards it that creates an expectation of healing that is therefore powerful, symptoms are truly alleviated.

[Kirsch: This is the placebo response...]

Kirsch, who's been studying placebos for 36 years, says "sugar pills" tin flame move miracles.

Kirsch: Placebos are non bad for treating a number of disorders: irritable bowel syndrome, repetitive strain injuries, ulcers, Parkinson's disease.

Even traumatic human knee pain. In this clinical lawsuit some patients alongside osteoarthritis underwent human knee surgery. While others had their knees only opened in addition to and therefore sewn right dorsum up.

Kirsch: And here's what happened. In price of walking in addition to climbing, the people who got the placebo truly did better--

Stahl: Come on.

Kirsch: --than the people who got the existent surgery.

Stahl: No.

Kirsch: And that lasted for a year. At 2 years afterwards surgery, at that spot was no divergence at all betwixt the existent operation in addition to the sham surgery.

Stahl: Is it all inwards your caput or--

Kirsch: Well, it's non all inwards your caput because the placebos tin flame also touching on your body. So if yous accept a placebo tranquilizer, you're probable to have got a lowering of blood pressure level in addition to pulse rate. Placebos tin flame decrease pain. And nosotros know that's non all inwards the heed also because nosotros tin flame rails that using neuro-imaging inwards the encephalon as well.

He says the doctors who prescribe the pills move role of the placebo effect.

Kirsch: H5N1 clinician who cares, who takes the time, who listens to you, who asks questions virtually your status in addition to pays attending to what yous say, that's the sort of attention that tin flame assistance facilitate a placebo effect.

He says he got into researching the outcome of antidepressants yesteryear accident.

Kirsch: I was interested inwards evaluating the size of the placebo effect. I truly didn't fifty-fifty attention virtually the drug outcome because everybody, including me, knew it worked. I used to refer patients to teach prescriptions. I didn't alter the focus of my move onto looking at the drug outcome until I saw the information from our foremost analysis.

What he saw was that it almost didn't affair what sort of pill doctors gave patients.

Kirsch: We fifty-fifty looked at drugs that are non considered antidepressants: tranquilizers, barbiturates. And attain yous know what? They had the same outcome as the antidepressants.

Stahl: Come on.

Kirsch: Really.

Kirsch was therefore surprised yesteryear his initial findings, he decided to attain a 2nd report - using information non exclusively from the drug companies' clinical trials that had been published inwards medical journals.

This fourth dimension he got information that weren't published but had been submitted to the FDA, which he got through the Freedom of Information Act.

Kirsch: These are the studies that showed no attain goodness of the antidepressant over the placebo. What they did is they took the to a greater extent than successful studies, they published most of them. They took their unsuccessful studies in addition to they didn't issue them.

Stahl: So when yous did your study, yous set all the trials together?

Kirsch: That's right.

Stahl: You're looking at patients who took the existent drug in addition to patients who took the placebo.

Kirsch: Yes.

Stahl: Did they teach every bit better, or did the ones who took the pills teach fifty-fifty a fiddling better?

Kirsch: If they were mildly or moderately depressed, yous don't run across whatsoever existent divergence at all. The exclusively house where yous teach a clinically meaningful divergence is at these rattling extreme levels of depression.

Stahl: Now look, psychiatrists nation the drug works.

Kirsch: Right.

Stahl: The drug companies in addition to their scientists nation the drug works. Maybe you're wrong.

Kirsch: Maybe. I'd add together to that, yesteryear the way, patients nation the drugs--

Stahl: Patients nation the drug works.

Kirsch: --work. And, for the patients in addition to the psychiatrists, it's clear why they would nation the drug works. They accept the drug; they teach better. Our information demo that as well.

Stahl: You're exactly proverb why they teach better.

Kirsch: That's right. And the argue they teach amend is non because of the chemicals inwards the drug. The divergence betwixt drug in addition to placebo is very, rattling small; in addition to inwards one-half the studies non-existent.

Kirsch in addition to his studies have got triggered a furious counterattack - mainly from psychiatrists, who are lining upwardly to defend the utilisation of antidepressants similar Dr. Michael Thase, a professor of psychiatry at the University of Pennsylvania School of Medicine, who has been a consultant to many of the drug companies.

Stahl: Irving Kirsch says that depressants are no amend than placebo for the vast bulk of people alongside depression, the vast majority. Do yous concur alongside that?

Michael Thase: No, no. I don't agree. I think you're confusing, or he's confusing, the results of studies versus what goes on inwards practice.

He says that Kirsch's statistical analysis overlooks the benefits to private patients.

[Thase alongside patient: Have a seat.]

And patch he agrees there's a substantial placebo outcome -

[Thase: Have yous been keeping rails of your depression scores?]

Especially for the mildly depressed, using a dissimilar methodology, he finds that the drugs assistance xiv per centum of those moderately depressed, in addition to fifty-fifty to a greater extent than for those severely depressed.

Thase: Our ain move indicates pretty convincingly that this is a large in addition to meaningful outcome for a subset of the patients inwards these studies.

Stahl: But fifty-fifty yesteryear your ain numbers to a greater extent than people, perhaps twice as many people, are having a placebo outcome than are truly beingness helped yesteryear the drug.

Thase: That's correct.

Stahl: In the moderate range?

Thase: That's correct.

Stahl: And this isn't troubling to you?

Thase: I want our antidepressants were stronger. I promise nosotros have got amend ones inwards the future. But that xiv per centum wages over in addition to inwards a higher house the placebo is for a status that afflicts millions of people, that represents hundreds of thousands of people who are amend parents, who are amend workers, who are happier in addition to who are less probable to accept their life.

Since the introduction of Prozac inwards the 1980s, prescriptions for these drugs have got soared 400 per centum -

[Commercial: I used to live happy, I think beingness happy...]

-- alongside the drug companies having spent billions over the years advertising them.

Stahl: I don't know virtually you, but I'm seeing to a greater extent than women running through daisy fields afterwards looking morose than ever before.

Dr. Walter Brown: Absolutely. There's a lot of hype out there.

Dr. Walter Brown is a clinical professor of psychiatry at Brown University's Medical School. He has co-authored 2 studies that largely corroborate Kirsch's findings.

Brown: The number of antidepressant prescriptions over the final decade has increased in addition to most troublesome, the biggest increment is inwards the mildly depressed, who are the ones who are to the lowest degree probable to attain goodness from them.

He says they're getting virtually no attain goodness from the chemic inwards the pill. Like most experts, he says these drugs attain move for the severely depressed, but he questions the widely held theory that depression is caused yesteryear a deficiency inwards the encephalon chemic called serotonin, which most of these pills target.

Brown: The experts inwards the champaign right away believe that that theory is a gross oversimplification in addition to in all likelihood is non correct.

Stahl: And the whole thought of antidepressants is built unopen to this theory?

Brown: Yes, it is.

To approve whatsoever drug, the Food in addition to Drug Administration only requires that companies demo their pill is to a greater extent than effective than a placebo inwards 2 clinical trials - fifty-fifty if many other drug trials failed.

Brown: The FDA for antidepressants has a fairly depression bar. H5N1 novel drug tin flame live no amend than placebo inwards 10 trials, but if 2 trials demo it to live better, it gets approved.

Stahl: Does that brand feel to you?

Brown: That's non the means I would attain it if I were the king. But I'm not.

Dr. Tom Laughren, managing director of the FDA's segmentation of psychiatry products, defends the approving process.

Stahl: We're told yous discard the negatives. Is that non right?

Tom Laughren: We consider everything that nosotros have. We aspect at those trials individually--

Stahl: But how are yous knowing that the 2 positives deserve bigger forcefulness inwards the decision?

Laughren: Getting that finding of a positive report yesteryear chance, if at that spot isn't truly an effect, is rattling low. I mean, that's basic statistics in addition to that's the means clinical trials are interpreted. H5N1 split enquiry is whether or non the outcome that you're seeing is clinically relevant.

Stahl: Okay. Is it clinically relevant?

Laughren: The information that nosotros have got shows that the drugs are effective.

Stahl: But what virtually the flat of effectiveness?

Laughren: I think nosotros all concur that the changes that yous run across inwards the short-term trials, the divergence betwixt improvement inwards drug in addition to placebo is rather small.

Stahl: It's a moderate difference.

Laughren: It's a small, it's a little difference.

It's therefore little - that inwards Great United Kingdom of Great Britain in addition to Northern Ireland of Britain in addition to Northern Republic of Ireland the National Health Service decided to dramatically revamp the means these drugs are prescribed. It did therefore afterwards commissioning its ain review of clinical trials.

Tim Kendall: We came to the conclusion that for mild to moderate depression, these drugs in all likelihood weren't worth having.

Stahl: At all.

Kendall: Not really.

Dr. Tim Kendall, a practicing psychiatrist in addition to co-director of the committee that did the review says that similar Irving Kirsch - they were surprised yesteryear what they flora inwards the drug companies' unpublished data.

Kendall: With the published evidence, it significantly overestimated the effectiveness of these drugs in addition to it underestimated the side effects.

Stahl: The FDA would nation that some of these unpublished studies are unpublished because at that spot were flaws inwards the means the trials were conducted.

Kendall: This is a multibillion dollar industry. I dubiety that they are spending $10 i thou one thousand per lawsuit to come upwardly up alongside a piteous methodology. What characterizes the unpublished is that they're negative. Now I don't think it's that their method is somehow wrong; it's that their outcome is non suitable from the company's dot of view.

Because of the review, novel world wellness guidelines were issued. Now drugs are given exclusively to the severely depressed as the foremost trace of treatment. For those alongside mild to moderate depression, the British authorities is spending nearly one-half a billion dollars preparation an regular army of speak therapists.

[Instructor: If yous wanna move a fiddling faster, yous can.]

Physical exercise is some other handling prescribed for the mildly depressed.

Kendall: By the terminate of 10 weeks, yous teach exactly as goodness a alter inwards their depression scores, as yous attain at the terminate of 10 or 12 weeks alongside an antidepressant.

None of the drug companies nosotros spoke to was willing to hold camera, but Eli Lilly told us inwards an e-mail that drug trials demo antidepressants move amend than placebos over the long term in addition to that "numerous studies have got shown that patients on placebos are to a greater extent than probable to relapse" dorsum into depression. The industry's merchandise association, PhRMA, wrote us: "antidepressants have got been shown to live tremendously effective."

But if Irving Kirsch has his way, the drug companies volition have got to completely rethink their $11.3 billion business.

Stahl: You're throwing a bomb into this. This is huge what you're saying.

Kirsch: I know that. The occupation is that yous tin flame teach the same attain goodness without drugs. I think to a greater extent than are get-go to agree. And I think things have got begun to change.

Everyone inwards this story says that if you're depressed, yous should run across your doctor, in addition to if you're already on these powerful drugs, yous shouldn't halt taking them on your own.

More Insight in addition to Advice from the

• How Alzheimer's Spreads Throughout the Brain
• Test Your Memory for Alzheimer's (5 Best Self Assessment Tests)
• What is Alzheimer's Disease?
• What is Dementia?
• What’s the Difference Between Alzheimer’s Disease in addition to Dementia
• Communicating inwards Alzheimers World
• How the Loss of Memory Works inwards Alzheimer’s Disease, in addition to How Understanding This Could Help You
• Learning How to Communicate alongside Someone Suffering From Alzheimer's Disease
• Alzheimer's World -- Trying to Reconnect alongside Someone Suffering from Alzheimer's Disease
• About the

Original content Bob DeMarco, the

Share this post